Smith A F, Macfie W G, Oliver M F
Br Med J. 1970 Apr 11;2(5701):86-8. doi: 10.1136/bmj.2.5701.86.
Serum creatine kinas (C.K.), aspartate amino-transferase (G.O.T.), and alkaline phosphatase (A.P.) activities were measured in 211 men with serum cholesterol concentrations in the upper one-third of the normal distribution. Of these, 110 were receiving clofibrate and 101 were given identical capsules containing olive oil. These investigations were also carried out on 85 healthy men with low serum cholesterol levels not receiving clofibrate.No differences were observed in C.K. and G.O.T. activities between any of these groups; A.P. was significantly lower in the clofibrate-treated group. No significant alterations in C.K. occurred during serial observations made in 15 patients with ischaemic heart disease over a period of five months. No instance of myalgia or muscle stiffness was recorded in 452 men who had received clofibrate for one year.It is concluded that raised C.K. and G.O.T. concentrations and the occurrence of myalgia are uncommon accompaniments of clofibrate treatment.
对血清胆固醇浓度处于正常分布上三分之一范围的211名男性进行了血清肌酸激酶(C.K.)、天冬氨酸转氨酶(G.O.T.)和碱性磷酸酶(A.P.)活性的测定。其中,110人接受氯贝丁酯治疗,101人服用了含橄榄油的相同胶囊。还对85名未接受氯贝丁酯治疗、血清胆固醇水平较低的健康男性进行了这些研究。这些组之间在C.K.和G.O.T.活性方面未观察到差异;氯贝丁酯治疗组的A.P.显著较低。在对15例缺血性心脏病患者进行的为期五个月的连续观察中,C.K.未出现显著变化。在接受氯贝丁酯治疗一年的452名男性中,未记录到肌痛或肌肉僵硬的病例。结论是,C.K.和G.O.T.浓度升高以及肌痛的发生并非氯贝丁酯治疗的常见伴随情况。